Recombinant immunotoxins for the treatment of haematological malignancies

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.4, Iss.7, 2004-07, pp. : 1115-1128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Proteomics in the Diagnosis and Treatment of Haematological Malignancies

Current Proteomics, Vol. 7, Iss. 3, 2010-10 ,pp. : 195-208

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant immunotoxins for cancer therapy

By Brinkmann Ulrich Keppler-Hafkemeyer Andrea Hafkemeyer Peter

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 693-702

Informa Healthcare

Access to resources Recommend Favorite

RNA interference for treating haematological malignancies

By Hexner Elizabeth O Gewirtz Alan M

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1585-1592

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Immunotoxins: From Basic Research to Cancer Therapy

By Brinkmann U. Pastan I.

Methods, Vol. 8, Iss. 2, 1995-10 ,pp. : 143-156

Academic Press

Access to resources Recommend Favorite

Generation of Active Immunotoxins Containing Recombinant Restrictocin

By Rathore D. Batra J.K.

Biochemical and Biophysical Research Communications, Vol. 222, Iss. 1, 1996-05 ,pp. : 58-63

Elsevier

Access to resources Recommend Favorite